https://kuraoncology.com/wp-content/uploads/AdobeStock_207889815-scaled.jpg
1709
2560
eallison
/wp-content/uploads/kura-logo-registered-blue.svg
eallison2021-04-21 08:00:332023-08-24 12:25:59Tipifarnib Demonstrates Encouraging Efficacy in Patients with Recurrent and/or Metastatic HNSCC with HRAS Mutations
Scroll to top
